Ledger.Open graph →
SEC Form D · filed March 30, 2017

Aerpio Pharmaceuticals, Inc

Offering
$41.8M
Sold
$41.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CINCINNATI, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Steven M. Prelack · Cincinnati, OHDirectorAnupam M. Dalal · Cincinnati, OHDirectorJoseph Gardner · Cincinnati, OHExec · DirectorStephen G. Pakola · Cincinnati, OHExecChau M. Khuong · Cincinnati, OHDirectorKevin G. Peters · Cincinnati, OHExecPaul M. Weiss · Cincinnati, OHDirectorCaley M. Castelein · Cincinnati, OHDirectorMuneer Satter · Lake Forest, CADirectorJames M. Murphy · Cincinnati, OHExecPravin M. Dugel · Cincinnati, OHDirectorMuneer Satter · Cincinnati, OHDirectorSteven M. Prelack · Cincinnati, OHDirectorAnupam M. Dalal · Cincinnati, OHDirectorJoseph Gardner · Cincinnati, OHExec · DirectorJames M. Murphy · Cincinnati, OHExecStephen G. Pakola · Cincinnati, OHExecPravin M. Dugel · Cincinnati, OHDirectorChau M. Khuong · Cincinnati, OHDirectorKevin G. Peters · Cincinnati, OHExecPaul M. Weiss · Madison, WIDirectorCaley M. Castelein · Cincinnati, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗